Citation Impact
Citing Papers
Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival
2008
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Receptor-Binding, Biodistribution, and Metabolism Studies of 64 Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors
2008
Expansive discovery of chemically diverse structured macrocyclic oligoamides
2024 StandoutScienceNobel
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy
2000
The type 2 human somatostatin receptor as a platform for reporter gene imaging
2002
Shedding light onto live molecular targets
2003 Standout
A comparison of 111In-DOTATOC and 111In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours
2004
Regional Radiochemotherapy Using In Situ Hydrogel
2005
Molecular imaging with copper-64
2004
Novel Receptor-Targeted Fluorescent Contrast Agents for In Vivo Tumor Imaging
2000
Optical imaging in drug discovery and diagnostic applications
2005
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Characterization of primary lesions caused by the plastome mutator of Oenothera
1996
In vitro and in vivo analysis of [64Cu-NO2A-8-Aoc-BBN(7–14)NH2]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors
2009
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)
2009
Nuclear Uptake and Dosimetry of 64Cu-Labeled Chelator Somatostatin Conjugates in an SSTr2-Transfected Human Tumor Cell Line
2007
Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(iv)–peptide bioconjugates
2012
Molecular imaging: The application of small animal positron emission tomography
2002
Structure and organization of Marchantia polymorpha chloroplast genome
1988
Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform
2001
Taking advantage of luminescent lanthanide ions
2005 Standout
Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice
2005
Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy
2013 StandoutNobel
[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study
2012
Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease
2010
Phaeochromocytoma
2005 Standout
Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: From molecular modeling to in vivo evaluation
2010
Production and Applications of Copper-64 Radiopharmaceuticals
2004
Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging
2012 Standout
Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s
2007
Compilation of tRNA sequences and sequences of tRNA genes
2004 Standout
In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor–Expressing Prostate Cancer
2011
68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future Perspectives
2011
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Preparation of high specific activity 86Y using a small biomedical cyclotron
2005
A homolog of a nuclear-coded iron-sulfur protein subunit of bovine mitochondrial complex I is encoded in chloroplast genomes
1991 StandoutNobel
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
2003 StandoutNobel
Radiolabeled high affinity peptidomimetic antagonist selectively targets αvβ3 receptor-positive tumor in mice
2007
Pre-clinical evaluation of [111In-DTPA-Pro1, Tyr4]bombesin, a new radioligand for bombesin-receptor scintigraphy
1999
DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals
2003
A new bifunctional chelator for copper radiopharmaceuticals: a cage amine ligand with a carboxylate functional group for conjugation to peptides
2009
The golden age: gold nanoparticles for biomedicine
2011 Standout
Fluorescent peptide probes for in vivo diagnostic imaging
2004
Using molecular beacons for cancer imaging and treatment
2007
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
2006
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
18F‐Labeling of Peptides by means of an Organosilicon‐Based Fluoride Acceptor
2006
The role of coordination chemistry in the development of target-specific radiopharmaceuticals
2004
αvβ3 Integrin‐targeting radionuclide therapy and imaging with monomeric RGD peptide
2008
Radiometallated peptides for molecular imaging and targeted therapy
2011
A practical guide to the construction of radiometallated bioconjugates for positron emission tomography
2011
Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount
1999
Update on the treatment of neuroendocrine tumors
2003
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. a new somatostatin analog with improved target tissue uptake
1999
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals
2008
What We Talk About When We Talk About Fat
2014 Standout
Demystifying the Effects of a Three‐Dimensional Microenvironment in Tissue Morphogenesis
2007
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
Somatostatin Analog Therapy in Treatment of Gastrointestinal Disorders and Tumors
2003
MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-releasing Peptide Receptor
2006
Fluorescent and colorimetric sensors for detection of lead, cadmium, and mercury ions
2011 Standout
Preparation and Biological Evaluation of 64Cu-CB-TE2A-sst2-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor–Positive Tumors
2008
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
Radiolabelling DOTA-peptides with 68Ga
2005
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
2010
Azobenzene photoswitches for biomolecules
2011 Standout
Design, synthesis and evaluation of near-infrared fluorescent pH indicators in a physiologically relevant range
2005
True radiotracers: Cu-64 targeting vectors based upon bombesin peptide
2009
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
A DOTA–peptide conjugate by copper-free click chemistry
2010
DOTAGA–Anhydride: A Valuable Building Block for the Preparation of DOTA‐Like Chelating Agents
2012
The 30-kilodalton subunit of bovine mitochondrial complex I is homologous to a protein coded in chloroplast DNA
1991 StandoutNobel
Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents
2002
Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
2008
Trends in peptide drug discovery
2021
Analysis of 81 genes from 64 plastid genomes resolves relationships in angiosperms and identifies genome-scale evolutionary patterns
2007 Standout
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
2006 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Comparison of Yttrium and Indium Complexes of DOTA-BA and DOTA-MBA: Models for 90Y- and 111In-Labeled DOTA−Biomolecule Conjugates
2002
Evaluation of a Maleimido Derivative of CHX-A′′ DTPA for Site-Specific Labeling of Affibody Molecules
2008
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Activatable Molecular Systems Using Homologous Near-Infrared Fluorescent Probes for Monitoring Enzyme Activitiesin Vitro,in Cellulo, andin Vivo
2009
Gastrin Releasing Protein Receptor Specific Gold Nanorods: Breast and Prostate Tumor Avid Nanovectors for Molecular Imaging
2009
Dual Integrin and Gastrin-Releasing Peptide Receptor Targeted Tumor Imaging Using 18F-labeled PEGylated RGD-Bombesin Heterodimer 18F-FB-PEG3-Glu-RGD-BBN
2008
Pyropheophorbide 2-Deoxyglucosamide: A New Photosensitizer Targeting Glucose Transporters
2003
Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals
2000
Radiolabeled somatostatin receptor antagonists are preferable to agonists forin vivopeptide receptor targeting of tumors
2006
Synthesis, Characterization, and X-ray Crystal Structure of In(DOTA-AA) (AA = p-Aminoanilide): A Model for 111In-Labeled DOTA-Biomolecule Conjugates
2003
Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition: Applications in Biological Imaging and Biomedicine
2006 Standout
Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.
1999
Radiolabeling and In Vivo Behavior of Copper-64-Labeled Cross-Bridged Cyclam Ligands
2001
Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes
2004
A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
2004
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Comparison of Four 64Cu-Labeled Somatostatin Analogues in Vitro and in a Tumor-Bearing Rat Model: Evaluation of New Derivatives for Positron Emission Tomography Imaging and Targeted Radiotherapy
1999
Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer.
2003
Synthesis, Copper(II) Complexation,64Cu-Labeling, and Bioconjugation of a New Bis(2-pyridylmethyl) Derivative of 1,4,7-Triazacyclononane
2008
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
2006 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency
2000
A Novel Approach to a Bifunctional Photosensitizer for Tumor Imaging and Phototherapy
2005
Structural modification strategies for the rational design of red/NIR region BODIPYs
2014 Standout
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression
2005
Compact Cysteine-Coated CdSe(ZnCdS) Quantum Dots for in Vivo Applications
2007 StandoutNobel
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
2004
Synthesis, Characterization and In Vivo Studies of Cu(II)-64-Labeled Cross-Bridged Tetraazamacrocycle-amide Complexes as Models of Peptide Conjugate Imaging Agents
2007
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Near-Infrared Fluorescent RGD Peptides for Optical Imaging of Integrin αvβ3Expression in Living Mice
2005
Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
2006
Optical Imaging of Matrix Metalloproteinase-7 Activity in Vivo Using a Proteolytic Nanobeacon
2008
Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging.
2008
Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.
2003
Multivalent Carbocyanine Molecular Probes: Synthesis and Applications
2004
H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals
2012
A homologue of the nuclear coded 49 kd subunit of bovine mitochondrial NADH-ubiquinone reductase is coded in chloroplast DNA.
1989 StandoutNobel
Location of the single gene for elongation factor Tu on the Euglena gracilis chloroplast chromosome.
1983
110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.
2002
Agonist−Antagonist Dilemma in Molecular Imaging: Evaluation of a Monomolecular Multimodal Imaging Agent for the Somatostatin Receptor
2007
Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
2005
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
1999
Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
2005
A Time Domain Fluorescence Tomography System for Small Animal Imaging
2008
Hexadentate Bispidine Derivatives as Versatile Bifunctional Chelate Agents for Copper(II) Radioisotopes
2009
Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator
2004
213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model
2006
Synthesis and Characterization of Two 111In-Labeled DTPA−Peptide Conjugates
2001
Characterization of Somatostatin Receptor Subtype 2 Expression in Stably Transfected A-427 Human Cancer Cells
2007
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Synthesis, Characterization, and Structures of Indium In(DTPA-BA2) and Yttrium Y(DTPA-BA2)(CH3OH) Complexes (BA = Benzylamine): Models for 111In- and 90Y-Labeled DTPA-Biomolecule Conjugates
2004
Multimodality Agents for Tumor Imaging (PET, Fluorescence) and Photodynamic Therapy. A Possible “See and Treat” Approach
2005
Pea chloroplast DNA encodes homologues of Escherichia coli ribosomal subunit S2 and the β'-subunit of RNA polymerase
1986 StandoutNobel
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
2015
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Copper‐64/61 and iodine‐125‐labeled dota‐DTYR1‐octreotate: A new somatostatin analog for labeling with metals and halogens
2001
Optical Systems for in Vivo Molecular Imaging of Cancer
2003
90Y and 111In Complexes of a DOTA-Conjugated Integrin αvβ3 Receptor Antagonist: Different but Biologically Equivalent
2004
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Surface Plasmon Resonance Scattering and Absorption of anti-EGFR Antibody Conjugated Gold Nanoparticles in Cancer Diagnostics: Applications in Oral Cancer
2005 Standout
Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues
2009
Synthesis and Evaluation of Polyhydroxylated Near-Infrared Carbocyanine Molecular Probes
2004
GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
2005
Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A Chelates for Targeted Positron Emission Tomography with an αvβ6-Specific Peptide
2009
Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium Reduces Food Intake and Body Weight
2010
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Synthesis and Evaluation of a Stable Bacteriochlorophyll-Analog and Its Incorporation into High-Density Lipoprotein Nanoparticles for Tumor Imaging
2009
Synthesis of Target-Specific Radiolabeled Peptides for Diagnostic Imaging
2002
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Infrared Absorbing Croconaine Dyes: Synthesis and Metal Ion Binding Properties
2007
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.
2001
Synthesis, 18F-Labeling, and in Vitro and in Vivo Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks
2008
In Vivo Transchelation of Copper-64 from TETA-Octreotide to Superoxide Dismutase in Rat Liver
2000
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
64Cu-Labeled Alpha-Melanocyte-Stimulating Hormone Analog for MicroPET Imaging of Melanocortin 1 Receptor Expression
2007
Works of Jack L. Erion being referenced
Radiolabeled RGD-DTPA-Tyr 3 -Octreotate for Receptor-Targeted Radionuclide Therapy
2004
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities
2003
Toxicity and dosimetry of177Lu-DOTA-Y3-octreotate in a rat model
2001
Characterization of the mRNA transcripts of the maize, ribulose-1,5-bisphosphate carboxylase, large subunit gene
1985
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
2001
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer
2003
Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma
2000
[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy
2001
Radiotherapeutic efficacy of 153Sm-CMDTPA-Tyr3-octreotate in tumor-bearing rats☆
2001
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate
2003
Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo
1998
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma
2009
Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides
2008
[177Lu‐DOTA0,Tyr3]octreotate for somatostatin receptor‐targeted radionuclide therapy
2001
Molecular Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors in Mice Using64Cu- and86Y-DOTA−(Pro1,Tyr4)-Bombesin(1−14)
2007
Anticancer activity of targeted proapoptotic peptides.
2006
The plastome mutator of Oenothera continues to function as originally described
1987
Euglena gracilis chloroplast EF-Ts. Evidence that it is a nuclear-coded gene product.
1980
<title>Site-specific tumor-targeted fluorescent contrast agents</title>
2001
Evaluation of a radiolabeled cyclic DTPA-RGD analog for tumor imaging and radionuclide therapy
2000
Synthesis, In Vitro Receptor Binding, and In Vivo Evaluation of Fluorescein and Carbocyanine Peptide-Based Optical Contrast Agents
2002
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
2002
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours
2007
Identification of the Solublein VivoMetabolites of Indium-111-Diethylenetriaminepentaacetic Acid-d -Phe1-Octreotide
1998
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.
1998
Novel Bioactive and Stable Neurotensin Peptide Analogues Capable of Delivering Radiopharmaceuticals and Molecular Beacons to Tumors
2003
DOTA−d -Tyr1-Octreotate: A Somatostatin Analogue for Labeling with Metal and Halogen Radionuclides for Cancer Imaging and Therapy
2002